Closed on Jun 22, 2026
Strengthening tuberculosis (TB) prevention, diagnosis, treatment, and surveillance in Asia
Centers for Disease Control-GHC · Opportunity number CDC-RFA-JG-26-0125
Details summarized from the official notice as of Jun 23, 2026. Always confirm eligibility, deadlines and requirements in the official notice before applying.
Independent platform. Not affiliated with or endorsed by any government agency. Data from public federal sources.
This opportunity is closed as of Jun 22, 2026.
It is kept here for reference. See the related open opportunities below, or check the official listing in case the agency posts a new cycle.
Key facts
| Opportunity number | CDC-RFA-JG-26-0125 |
|---|---|
| Agency | Centers for Disease Control-GHC Department of Health and Human Services |
| Assistance listing (ALN, formerly CFDA) | 93.494 |
| Posted | May 22, 2026 |
| Deadline | Jun 22, 2026 |
| Expected number of awards | 3 |
| Cost sharing or matching required | No |
| Funding type | Cooperative agreement |
| Category | Health |
| Last updated here | Jun 23, 2026 |
Summary from the notice
The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $3,000,000 for Year 1, subject to the availability of funds.The purpose of this NOFO is to reduce TB-related morbidity and mortality in India, the Philippines, and Vietnam by strengthening:• TB case finding, including linked activities such as screening, testing, and diagnostic evaluation.• TB prevention, including TB preventive treatment (TPT).• TB treatment, including linkage and improved treatment regimens, as appropriate.• Surveillance, through adopting, evaluating, and expanding innovative approaches.Activities implemented will focus on:• Expanding and improving diagnosis of TB infection and TB disease, including early and asymptomatic TB as well as drug-resistant or multidrug-resistant TB. This will be done by using and evaluating innovative screening and diagnostic methods and scaling up evidence-based approaches. • Improving TPT outcomes for all individuals at high risk of developing TB disease and improving TB treatment outcomes of individuals with TB disease, including those with drug-resistant or multidrug-resistant TB. This will be done by using new, shorter, and better-tolerated treatment regimens.• Strengthening TB surveillance for data-driven decision making, program planning, and public health action.Asia carries the highest burden of TB and drug-resistant or multidrug-resistant TB globally. This NOFO will focus on activities in India, the Philippines, and Vietnam because they are three of the top four countries contributing to the TB burden in the U.S. This aligns with the America First Global Health Strategy.
Who can apply
The official notice lists these applicant types as eligible:
- Federally recognized tribal governments
- Other Native American tribal organizations
- Private colleges and universities
- County governments
- Small businesses
- Nonprofits without 501(c)(3) status (other than colleges)
- Special district governments
- Independent school districts
- Public and state colleges and universities
- State governments
- City or township governments
- Public and Indian housing authorities
- Nonprofits with 501(c)(3) status (other than colleges)
- Unrestricted (open to any type of entity, check the notice)
- For-profit organizations other than small businesses
Registrations you will likely need
Most applications submitted through Grants.gov need the following. Registration can take several weeks, so start early. The notice lists the exact requirements.
- SAM.gov registration for your organization, which also gives you a Unique Entity ID (UEI). Registration is free.
- A Login.gov account, which Grants.gov uses for sign-in.
- A Grants.gov applicant registration linked to your organization's UEI.
Related open opportunities
Strengthening Ghana Health Service laboratory services, diagnostic networks, and systems for a more effective, efficient, and sustainable response to HIV, TB, and other priority health threats
Centers for Disease Control-GHC · CDC-RFA-JG-26-0178
Deadline:
Oct 16, 2026
(closes today)
Health
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-077
Deadline:
Oct 16, 2026
(closes today)
Up to: $300,000
Health
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
National Institutes of Health · PAR-25-155
Deadline:
Oct 19, 2026
(3 days left)
Up to: $50,000
Health
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
National Institutes of Health · RFA-DE-27-001
Deadline:
Oct 19, 2026
(3 days left)
Health
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health · RFA-CA-27-021
Deadline:
Oct 19, 2026
(3 days left)
Up to: $600,000
Health